Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study

Positron Emission Tomography (PET) is an important neuroimaging tool to quantify the distribution of specific molecules in the brain. The quantification is based on a series of individually designed data preprocessing steps (pipeline) and an optimal preprocessing strategy is per definition associated with less noise and improved statistical power, potentially allowing for more valid neurobiological interpretations. In spite of this, it is currently unclear how to design the best preprocessing pipeline and to what extent the choice of each preprocessing step in the pipeline minimizes subject-specific errors. To evaluate the impact of various preprocessing strategies, we systematically examined 384 different pipeline strategies in data from 30 healthy participants scanned twice with the serotonin transporter (5-HTT) radioligand [11C]DASB. Five commonly used preprocessing steps with two to four options were investigated: (1) motion correction (MC) (2) co-registration (3) delineation of volumes of interest (VOI's) (4) partial volume correction (PVC), and (5) kinetic modeling. To quantitatively compare and evaluate the impact of various preprocessing strategies, we used the performance metrics: test-retest bias, within- and between-subject variability, the intraclass-correlation coefficient, and global signal-to-noise ratio. We also performed a power analysis to estimate the required sample size to detect either a 5% or 10% difference in 5-HTT binding as a function of preprocessing pipeline. The results showed a complex downstream dependency between the various preprocessing steps on the performance metrics. The choice of MC had the most profound effect on 5-HTT binding, prior to the effects caused by PVC and kinetic modeling, and the effects differed across VOI's. Notably, we observed a negative bias in 5-HTT binding across test and retest in 98% of pipelines, ranging from 0 to 6% depending on the pipeline. Optimization of the performance metrics revealed a trade-off in within- and between-subject variability at the group-level with opposite effects (i.e. minimization of within-subject variability increased between-subject variability and vice versa). The sample size required to detect a given effect size was also compromised by the preprocessing strategy, resulting in up to 80% increases in sample size needed to detect a 5% difference in 5-HTT binding. This is the first study to systematically investigate and demonstrate the effect of choosing different preprocessing strategies on the outcome of dynamic PET studies. We provide a framework to show how optimal and maximally powered neuroimaging results can be obtained by choosing appropriate preprocessing strategies and we provide recommendations depending on the study design. In addition, the results contribute to a better understanding of methodological uncertainty and variability in preprocessing decisions for future group- and/or longitudinal PET studies.

[1]  B. Turk,et al.  Control of serotonin transporter phosphorylation by conformational state , 2016, Proceedings of the National Academy of Sciences.

[2]  Jeih-San Liow,et al.  Linearized Reference Tissue Parametric Imaging Methods: Application to [11C]DASB Positron Emission Tomography Studies of the Serotonin Transporter in Human Brain , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  A. Lammertsma,et al.  Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.

[4]  Andrew J. Reader,et al.  Impact of Image-Space Resolution Modeling for Studies with the High-Resolution Research Tomograph , 2008, Journal of Nuclear Medicine.

[5]  Lucas Rischka,et al.  Simple and rapid quantification of serotonin transporter binding using [11C]DASB bolus plus constant infusion , 2017, NeuroImage.

[6]  Xiao Jin,et al.  Evaluation of motion correction methods in human brain PET imaging--a simulation study based on human motion data. , 2013, Medical physics.

[7]  Jeih-San Liow,et al.  PET [11C]DASB imaging of serotonin transporters in patients with alcoholism. , 2007, Alcoholism, clinical and experimental research.

[8]  Olaf B. Paulson,et al.  MR-based automatic delineation of volumes of interest in human brain PET images using probability maps , 2005, NeuroImage.

[9]  Kris Thielemans,et al.  Correction of head movement on PET studies: comparison of methods. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  Laurence R. Meyerson,et al.  Diurnal concordance of human platelet serotonin content and plasma alpha-1-acid glycoprotein concentration , 1989, Pharmacology Biochemistry and Behavior.

[11]  Hartwig R. Siebner,et al.  The Center for Integrated Molecular Brain Imaging (Cimbi) database , 2016, NeuroImage.

[12]  Masanori Ichise,et al.  Reduced serotonin transporter binding in the insular cortex in patients with obsessive–compulsive disorder: A [11C]DASB PET study , 2010, NeuroImage.

[13]  J. John Mann,et al.  Positron Emission Tomography Quantification of Serotonin Transporter in Suicide Attempters with Major Depressive Disorder , 2013, Biological Psychiatry.

[14]  J. Luthardt,et al.  Effortful control as a dimension of temperament is negatively associated with prefrontal serotonin transporter availability in obese and non‐obese individuals , 2016, The European journal of neuroscience.

[15]  Vibe G. Frokjaer,et al.  Serotonin transporter binding in the hypothalamus correlates negatively with tonic heat pain ratings in healthy subjects: A [11C]DASB PET study , 2011, NeuroImage.

[16]  Rupert Lanzenberger,et al.  Cerebral serotonin transporter measurements with [11C]DASB: A review on acquisition and preprocessing across 21 PET centres , 2019, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[17]  Bruce Fischl,et al.  Accurate and robust brain image alignment using boundary-based registration , 2009, NeuroImage.

[18]  D. Greve,et al.  Cerebellar heterogeneity and its impact on PET data quantification of 5-HT receptor radioligands , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[19]  Ioana L. Coman,et al.  A comparison of FreeSurfer-generated data with and without manual intervention , 2015, Front. Neurosci..

[20]  Masanori Ichise,et al.  PET imaging of serotonin transporters with [11C]DASB: test-retest reproducibility using a multilinear reference tissue parametric imaging method. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  Alan A. Wilson,et al.  Positron Emission Tomography Quantification of [11C]-DASB Binding to the Human Serotonin Transporter: Modeling Strategies , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[22]  A M Dale,et al.  Measuring the thickness of the human cerebral cortex from magnetic resonance images. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Nikos Makris,et al.  Automatically parcellating the human cerebral cortex. , 2004, Cerebral cortex.

[24]  N. Volkow,et al.  Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[25]  Bruce R. Rosen,et al.  A regularized full reference tissue model for PET neuroreceptor mapping , 2016, NeuroImage.

[26]  Alan A. Wilson,et al.  Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study. , 2001, The American journal of psychiatry.

[27]  L. Freire,et al.  Motion Correction Algorithms May Create Spurious Brain Activations in the Absence of Subject Motion , 2001, NeuroImage.

[28]  Lars Kai Hansen,et al.  The Quantitative Evaluation of Functional Neuroimaging Experiments: The NPAIRS Data Analysis Framework , 2000, NeuroImage.

[29]  R. Parsey,et al.  In vivo Quantification of Serotonin Transporters Using [11C]DASB and Positron Emission Tomography in Humans: Modeling Considerations , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[30]  Stephen C. Strother,et al.  An Automated, Adaptive Framework for Optimizing Preprocessing Pipelines in Task-Based Functional MRI , 2015, PloS one.

[31]  M Slifstein,et al.  Validation and Reproducibility of Measurement of 5-HT1A Receptor Parameters with [carbonyl-11C]WAY-100635 in Humans: Comparison of Arterial and Reference Tissue Input Functions , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[32]  S. Houle,et al.  Serotonin transporter binding is reduced in seasonal affective disorder following light therapy , 2016, Acta psychiatrica Scandinavica.

[33]  Y. Okubo,et al.  Occupancy of serotonin transporter by tramadol: a positron emission tomography study with [11C]DASB. , 2014, The international journal of neuropsychopharmacology.

[34]  J. Ball,et al.  Statistics review 4: Sample size calculations , 2002, Critical care.

[35]  Stanley M. Garn Statistics: A Review* , 2009 .

[36]  G. Kranz,et al.  Effects of Selective Serotonin Reuptake Inhibitors on Interregional Relation of Serotonin Transporter Availability in Major Depression , 2017, Front. Hum. Neurosci..

[37]  R. Regenthal,et al.  The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive-compulsive disorder. , 2011, The international journal of neuropsychopharmacology.

[38]  Claus Svarer,et al.  Attenuation Correction for the HRRT PET-Scanner Using Transmission Scatter Correction and Total Variation Regularization , 2013, IEEE Transactions on Medical Imaging.

[39]  A. Evans,et al.  Correction for partial volume effects in PET: principle and validation. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[40]  M. Sibomana,et al.  Spatial resolution of the HRRT PET scanner using 3D-OSEM PSF reconstruction , 2009, 2009 IEEE Nuclear Science Symposium Conference Record (NSS/MIC).

[41]  R. Ogden,et al.  A hybrid deconvolution approach for estimation of in vivo non-displaceable binding for brain PET targets without a reference region , 2017, PloS one.

[42]  Anders M. Dale,et al.  Reliability in multi-site structural MRI studies: Effects of gradient non-linearity correction on phantom and human data , 2006, NeuroImage.

[43]  Quanzheng Li,et al.  Partial volume correction for PET quantification and its impact on brain network in Alzheimer’s disease , 2017, Scientific Reports.

[44]  Claus Svarer,et al.  A High-Resolution In Vivo Atlas of the Human Brain's Serotonin System , 2017, The Journal of Neuroscience.

[45]  Claus Svarer,et al.  High familial risk for mood disorder is associated with low dorsolateral prefrontal cortex serotonin transporter binding , 2009, NeuroImage.

[46]  Ronald Boellaard,et al.  Attenuation correction of PET activation studies in the presenceof task-related motion , 2003, NeuroImage.

[47]  Hervé Abdi,et al.  Optimizing preprocessing and analysis pipelines for single‐subject fMRI. I. Standard temporal motion and physiological noise correction methods , 2012, Human brain mapping.

[48]  Habib Zaidi,et al.  Partial Volume Correction Strategies in PET. , 2007, PET clinics.

[49]  Claus Svarer,et al.  Role of Serotonin Transporter Changes in Depressive Responses to Sex-Steroid Hormone Manipulation: A Positron Emission Tomography Study , 2015, Biological Psychiatry.

[50]  M. Stella Atkins,et al.  Iterating Registration and Activation Detection to Overcome Activation Bias in fMRI Motion Estimates , 2003, MICCAI.

[51]  Alan A. Wilson,et al.  Imaging the serotonin transporter with positron emission tomography: initial human studies with [11C]DAPP and [11C]DASB , 2000, European Journal of Nuclear Medicine.

[52]  L. K. Hansen,et al.  The Quantitative Evaluation of Functional Neuroimaging Experiments: The NPAIRS Data Analysis Framework , 2000, NeuroImage.

[53]  Bruce R. Rosen,et al.  Cortical surface-based analysis reduces bias and variance in kinetic modeling of brain PET data , 2014, NeuroImage.

[54]  Ciprian Catana,et al.  Different partial volume correction methods lead to different conclusions: An 18F-FDG-PET study of aging , 2016, NeuroImage.

[55]  Mark Slifstein,et al.  Estimation of serotonin transporter parameters with 11C-DASB in healthy humans: reproducibility and comparison of methods. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[56]  Colin Studholme,et al.  An overlap invariant entropy measure of 3D medical image alignment , 1999, Pattern Recognit..